Carbonyl scavenger and antiatherogenic effects of hydrazine derivatives

被引:90
作者
Galvani, Sylvain
Coatrieux, Christelle
Elbaz, Meyer
Grazide, Marie-Helene [2 ]
Thiers, Jean-Claude [2 ]
Parini, Angelo
Uchida, Koji [3 ]
Kamar, Nassim [4 ]
Rostaing, Lionel [4 ]
Baltas, Michel [5 ]
Salvayre, Robert [2 ]
Negre-Salvayre, Anne [1 ,2 ]
机构
[1] CHU Rangueil, IFR 31, UMR 858, Inserm,I2MR, F-31432 Toulouse 4, France
[2] Univ Toulouse 3, Fac Med Rangueil, Dept Biochem, F-31062 Toulouse, France
[3] Nagoya Univ, Lab Food & Biodynam, Nagoya, Aichi 4648601, Japan
[4] CHU Rangueil, Dept Nephrol Dialysis & Multiorgan Transplantat, F-31432 Toulouse 4, France
[5] CNRS, UMR 5068, LSPCMIB, F-75700 Paris, France
关键词
Carbonyl scavenger; Hydrazine; Lipoproteins; Oxidation; 4-Hydroxynonenal; Atherosclerosis;
D O I
10.1016/j.freeradbiomed.2008.08.026
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Reactive carbonyl compounds (RCC) generated by polyunsaturated fatty acid oxidation alter progressively cellular and tissular proteins by forming adducts on free amino groups and thiol residues (carbonyl stress). Carbonyl scavengers may neutralize RCC, but their protective effect in atherosclerosis has not been extensively studied. We report the carbonyl scavenger and antiatherogenic properties of hydrazine derivatives, namely hydralazine, an antihypertensive drug, isoniazid, an antituberculosis agent, and two antidepressants, phenelzine and iproniazid. These drugs were Poorly efficient in preventing the oxidation of LDL mediated by smooth muscle cells (SMCs), but inhibited the toxicity of UV-oxidized LDL (oxLDL) and of 4-hydroxynonenal (4-HNE). Hydrazine derivatives prevented the formation of foam cells resulting from LDL oxidation in human macrophagic U937 cells, and blocked the carbonyl stress in SMCs, by inhibiting the decrease in free amino group content, the increase in carbonylated proteins, and the formation of 4-HNE adducts on PDGFR. Experimental studies carried out on apoE-/- mice supplemented with drugs (30 mg/L in drinking water) showed a significant carbonyl stress inhibition correlated with a net reduction of atherosclerotic lesion development. In conclusion, these data indicate that hydrazine derivatives exhibit carbonyl scavenger and antiatherogenic properties, which opens novel therapeutical approaches for atherosclerosis and its cardiovascular complications. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:1457 / 1467
页数:11
相关论文
共 52 条
[1]
Aslam S, 2008, CURR OPIN NEPHROL HY, V17, P99
[2]
Glycoxidation and lipoxidation in atherogenesis [J].
Baynes, JW ;
Thorpe, SR .
FREE RADICAL BIOLOGY AND MEDICINE, 2000, 28 (12) :1708-1716
[3]
Oxidatively modified proteins in aging and disease [J].
Beal, MF .
FREE RADICAL BIOLOGY AND MEDICINE, 2002, 32 (09) :797-803
[4]
Is there a future for antioxidants in atherogenesis? [J].
Brigelius-Flohé, R ;
Kluth, D ;
Banning, A .
MOLECULAR NUTRITION & FOOD RESEARCH, 2005, 49 (11) :1083-1089
[5]
Inhibition of the renin-angiotensin system abolishes the proatherogenic effect of uremia in apolipoprotein E-deficient mice [J].
Bro, Susanne ;
Binder, Christoph J. ;
Witztum, Joseph L. ;
Olgaard, Klaus ;
Nielsen, Lars B. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (05) :1080-1086
[6]
BROOKE I, 1997, PHENYLHYDRAZINE
[7]
RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice [J].
Bucciarelli, LG ;
Wendt, T ;
Qu, W ;
Lu, Y ;
Lalla, E ;
Rong, LL ;
Goova, MT ;
Moser, B ;
Kislinger, T ;
Lee, DC ;
Kashyap, Y ;
Stern, DM ;
Schmidt, AM .
CIRCULATION, 2002, 106 (22) :2827-2835
[8]
Protein adduct-trapping by hydrazinophthalazine drugs: Mechanisms of cytoprotection against acrolein-mediated toxicity [J].
Burcham, PC ;
Fontaine, FR ;
Kaminskas, LM ;
Petersen, DR ;
Pyke, SM .
MOLECULAR PHARMACOLOGY, 2004, 65 (03) :655-664
[9]
Hydralazine inhibits rapid acrolein-induced protein oligomerization: Role of aldehyde scavenging and adduct trapping in cross-link blocking and cytoprotection [J].
Burcham, PC ;
Pyke, SM .
MOLECULAR PHARMACOLOGY, 2006, 69 (03) :1056-1065
[10]
Carmody Melinda S, 2007, Cardiol Rev, V15, P46, DOI 10.1097/01.crd.0000250840.15645.fb